Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma
N. Yamazaki, Y. Kiyohara, H. Uhara, H. Iizuka, J. Uehara, F. Otsuka, Y. Fujisawa, T. Takenouchi, T. Isei, K. Iwatsuki, H. Uchi, H. Ihn, H. Minami, H. Tahara
Cancer Science